Research interests

Designing hepatitis C virus (HCV) E1E2 glycoproteins for structural studies and vaccine studies.

Producing and designing novel HIV-1 envelope glycoproteins.

specialisation

hepatitis C virus (HCV), HIV-1, envelope glycoproteins, vaccines, nanoparticles

Research output

  1. A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers (npj Vaccines, (2021), 6, 1, (103), 10.1038/s41541-021-00364-x)

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  3. Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers

    Research output: Contribution to journal › Article › Academic › peer-review

View all (32) »

ID: 85314